AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Indiana University School of Medicine at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Indiana University School of Medicine brings 4 presentations to AMP 2026 in Seattle. Its program spans pharmacogenomics and laboratory policy, from a reference material for genotyping AMP's tier 1 and tier 2 pharmacogenomic variants to putting DPYD testing guidelines into practice. It also joins a session on laboratory payment policy and assesses an all-inclusive Duoseq sequencing assay in multiple myeloma.

OrganizationAMP 2026 Attendance
Med centres
Medical school in Indianapolis, the teaching arm of Indiana University Health, with pathology and laboratory medicine training and molecular diagnostics.
Workshop
Wed, Nov 11
12:00pm–12:50pm
DPYD - From Guidelines to Implementation
Testing DPYD variants before fluoropyrimidine chemotherapy: which variants to include, translating results to dose, and adoption barriers.
Workshop hosted by Agena Bioscience

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Indiana University School of Medicine

Tell us what you sell and we’ll find the people at Indiana University School of Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction